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In an article in the January/February 2000 issue of Society
titled “Race and Mortality,” I explained the statistical
pattern, inherent in other than highly irregular risk distri-
butions, whereby the rarer an outcome, the greater tends
to be the relative (percentage) difference between the rates
at which advantaged and disadvantaged groups experi-
ence the outcome and the smaller tends to be the relative
difference between rates at which such groups avoid the
outcome. By way of example with respect to the health
and healthcare outcomes on which the article principally
focused, as mortality declines, relative differences in mor-
tality tend to increase while relative differences in surviv-
al tend to decrease; as healthcare generally improves,
relative differences in receipt of appropriate care tend to
decrease while relative differences in failing to receive
such care tend to increase. In 2000, however, this pattern
was virtually unknown to health disparities researchers or
anyone else examining demographic differences in favor-
able or adverse outcomes. Consequently, most efforts to
appraise demographic differences in such outcomes were
fundamentally unsound.
This article addresses the extent to which the appraisal
of demographic differences in outcome rates is any sound-
er today than it was in 2000. In summary, while there has
been increasing recognition of the ways that relative dif-
ferences in outcome rates tend to be systematically affect-
ed by the prevalence (frequency) of an outcome, that
recognition has yet to affect the way observers analyze
group differences in outcome rates in any context. Though
today vastly greater resources are devoted to the study of
disparities in health and healthcare outcomes than in
2000, almost nothing said about such things as whether
those disparities have increased or decreased over time or
are otherwise larger in one setting than another, or even
whether a disparity should be deemed large or small, has
had a sound statistical basis. Meanwhile, federal regula-
tors encourage mortgage lenders and public schools to
reduce the frequency of adverse borrowing and student
discipline outcomes in order to reduce the commonly
observed severalfold racial and ethnic differences in rates
of experiencing those outcomes. Neither the regulators,
the congressional committees monitoring regulator poli-
cies, nor the institutions reducing the frequency of those
outcomes in response to federal encouragements under-
stand that reducing any outcome tends to increase, not
reduce, relative differences in experiencing it. More
broadly, events since 2000 do little to bolster one’s faith
in the validity of accepted scholarship or the capability of
individuals or institutions to recognize and acknowledge
that things they have been doing for decades or genera-
tions have been incorrect or misleading.
Relative Differences in Favorable and Adverse Outcomes
The pattern by which relative differences in experiencing
and avoiding an outcome exhibit reverse correlations with
the prevalence of an outcome can be well illustrated with
hypothetical test score data. Suppose that at a particular
cutoff failure rates are 20 % for an advantaged group
(AG) and 37 % for a disadvantaged group (DG). At this
cutoff DG’s failure rate is 1.85 times AG’s failure rate
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(37 %/20 %), while AG’s pass rates is 1.27 times DG’s
pass rate (80 %/63 %).1 If the cutoff is lowered to a point
where only 5 % of AG fails the test, assuming normal test
score distributions, DG’s failure rate would be about
13 %. With the lower cutoff, DG’s failure rate would be
2.60 times AG’s failure rate (13 %/5 %), while AG’s pass
rate would be only 1.09 times DG’s pass rates (95 %/87 %).
Thus, when test failure became less common, the relative
difference in failure rates increased while the relative differ-
ence in pass rates decreased.
The numbers in this example are set out in Table 1. The
table also shows the absolute (percentage point) difference
between the pass (and fail) rates of the two groups. But I will
defer for some pages discussion of that measure and the way
that it, too, tends to be systematically affected by the preva-
lence of an outcome.
A similar pattern can be found in virtually any data show-
ing the proportions of groups defined by race, gender, educa-
tion, income, or any other characteristic falling above or below
different points on a continuum of quantifiable factors associ-
ated with experiencing an outcome or simply showing the
rates at which the different groups experience or avoid an
outcome at different levels of overall prevalence. Income data
show that generally lowering poverty will tend to increase
relative differences in poverty rates while reducing relative
differences in rates of avoiding poverty, while general in-
creases in poverty will have the opposite effect.
Table 2 illustrates these effects using data from my Spring
2006 Chance editorial titled “Can We Actually Measure
Health Disparities?” The table presents the same type of
information as in Table 1. But in this case the adverse outcome
is having an income below 125 %, 100 %, or 75 % of the
poverty line, while the favorable outcome is having an income
above those points.
The final column presents a figure identified as “EES” for
“estimated effect size,” which is a measure of association
unaffected by the prevalence of an outcome. But, as with the
absolute difference, I will defer discussion of the measure for
some pages.
For instant purposes, I merely note that the second and third
rows of the table demonstrate the previously mentioned con-
trasting effects of decreases in poverty on relative differences
in rates of experiencing and avoiding poverty, as where, for
example, everyone previously with an income above 75 % of
the poverty line is able to escape poverty (i.e., an increase in
the relative difference between black and white poverty rates
and a decrease in the relative difference between black and
white rates of avoiding poverty). The second and first rows
similarly illustrate the contrasting effects on the two relative
differences where there occurs an increase in poverty such as
to pull into poverty everyone previously with an income
below 125 % of the poverty line (i.e., a decrease in the relative
difference between black and white poverty rates and an
increase in the relative difference between black and white
rates of avoiding poverty).
The reader would be well served at this point to fully grasp
the meaning of the two rate ratio columns in Table 2. And, in
light of the implications of the patterns of changes in those
columns as the table simulates general changes in the preva-
lence of poverty, the reader should consider whether there ever
could be circumstances warranting the devoting of resources
to exploring why black-white differences in either poverty
rates or rates of avoiding poverty changed during periods of
general increases or decreases in poverty without consider-
ation of the patterns described here. That is, could it make
sense, for example, to attempt to determine whether a partic-
ular administration’s manner of enforcing civil rights laws had
a role in those changes without consideration of the extent to
which the differences between rates changed simply because
there occurred a general increase or decrease in poverty? If the
answer to that question is not yet clear, it should become clear
enough in due course.
National Health and Nutrition Survey data show that gen-
erally lowering blood pressure will tend to increase relative
differences in hypertension while reducing relative differences
in rates of avoiding hypertension and that generally improving
folate levels will tend to increase relative differences in low
1 The 1.85 and 1.27 figures are usually termed “relative risks,” “risk
ratios,” or “rate ratios” (RR). The relative difference is RRminus 1 where
RR is greater than 1 (in which case the larger the RR the larger the relative
difference) and 1 minus RR where RR is less than 1 (in which case the
smaller the RR the larger the relative difference). I generally use the larger
figure as the numerator of the RR for both favorable and adverse out-
comes. Thus, as to both outcomes, the larger the RR the larger the relative
difference. Whether one uses the larger or smaller figure as the numerator
in RR can affect the size of a relative difference. For example, in a case
were rates are 10% and 20%, the former could be deemed 50% less than
the latter (RR=0.5) or the latter could be deemed 100 % greater than the
former (RR=2.0). But choice of numerator is irrelevant to issues about
the comparative sizes of relative differences addressed here.
Table 1 Fail and pass rates of advantaged group (AG) and disadvantaged group (DG) at different cutoffs, with measures of difference between rates
Cutoff AG fail DG fail AG pass DG pass DG/AG fail ratio AG/DG pass ratio Percentage point diff
High 20 % 37 % 80 % 63 % 1.85 1.27 17
Low 5 % 13 % 95 % 87 % 2.60 1.09 8
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folate while reducing relative differences in adequate folate;
credit score data show that lowering a credit score requirement
will tend to increase relative differences in failing to meet it
while reducing relative differences in meeting it. Similarly,
published life tables show that relative racial and gender
differences in mortality are generally greater among the young
than the old, while relative differences in survival are gener-
ally greater among the old than the young. Many tabular and
graphical illustrations of the pattern by which the two relative
differences tend to be affected by the prevalence of an out-
come based on a wide range of data, including that from
varied studies in medical and health policy journals, are avail-
able by means of the pages and subpages devoted to measure-
ment issues on jpscanlan.com.2
Despite the fact that the described pattern by which the two
relative differences tend to be affected by the prevalence of an
outcome is evident in so many publicly available types of
data, as well as hundreds or thousands of published studies –
and that I had been describing it in various, sometimes prom-
inent, forums since 19873 – when “Race and Mortality” was
published in 2000, the pattern was yet to be recognized in the
wide range of activities in the law and the social and medical
sciences where observers relied on relative differences in
some favorable or adverse outcome to quantify demographic
differences. Indeed, so far as the published record reflects, no
one analyzing group differences recognized that it was possi-
ble for the two relative differences to change in opposite
directions, much less that they tend to do so systematically.
Following substantial declines in mortality and other adverse
health outcomes in preceding decades, with corresponding
increases in relative differences in experiencing such out-
comes, observers took for granted that differences in the health
of advantaged and disadvantaged groups had increased.
Sometimes they even noted that the increases occurred “de-
spite” general declines in the adverse outcome. But no one
studying the issues either in the United States or abroad
recognized the extent to which increasing relative differences
in adverse health outcomes were to be expected simply be-
cause of the general declines in such outcomes and without
consideration of whether relative differences in the opposite
(favorable) outcomes had decreased.
Similarly, observers drew a range of inferences from the
fact that relative racial or socioeconomic differences in ad-
verse outcomes tended to be large among advantaged popu-
lations or subpopulations. Invariably, however, they failed to
consider the reasons to expect large relative difference in
adverse outcomes to be large wherever such outcomes are
comparatively rare.
On the other hand, as rates of receipt of beneficial
healthcare procedures like immunization and mammography
increased, relative differences in receipt of such procedures
tended to decrease while relative differences in failing to
receive them tended to increase. And, because the convention
was to measure healthcare disparities in terms of relative
differences in favorable outcomes, disparities in such out-
comes commonly were deemed to be decreasing. But here,
too, such appraisals were made without regard to the extent to
which the observed patterns were functions of general in-
creases in receipt of such procedures.
As explained in “Race andMortality,” the pattern by which
the two relative differences tend to change in opposite direc-
tion as the prevalence of an outcome changes will not be
2 The principal pages are Measuring Health Disparities, Scanlan’s Rule,
Mortality and Survival, Measuring Association, Immunization Dispar-
ities, Lending Disparities, Discipline Disparities, Educational Disparities,
Disparate Impact, and Feminization of Poverty. As of the middle of 2014,
these pages had something in excess of eighty subpages. Useful collec-
tions of graphical and tabular illustrations may be found in my October
2012 applied statistics workshop at Harvard’s Institute for Quantitative
Social Science (“The Mismeasure of Group Differences in the Law and
the Social and Medical Sciences”), my September 2013 paper for a
University of Kansas School of Law faculty workshop (“TheMismeasure
of Discrimination”), and my paper and presentation from the November
2013 Federal Committee on Statistical Methodology (FCSM) 2013 Re-
search Conference (“Measuring Health and Healthcare Disparities”). I
will refer to some of these illustrations later in this article.
3 These articles are listed on the Bibliography subpage of the Scanlan’s
Rule page. The most significant was probably “The Perils of Provocative
Statistics” in theWinter 1991 issue of The Public Interest. Like “Race and
Mortality,” a number of the articles discussed themistaken attention given
to the so-called “feminization of poverty” by observers who failed to
recognize that reductions in poverty (including the poverty of female-
headed families) tended to increase the feminization of poverty, while
increases in poverty (including the poverty of female-headed families)
tended to reduce the feminization of poverty. That subject was also
addressed in my article in the January/February 1992 issue of Society
titled “The Curious Case of Affirmative Action for Women.”



















125 % 14.9 % 31.0 % 85.1 % 69.0 % 2.08 1.23 16.1 0.54
100 % 10.8 % 24.7 % 89.2 % 75.3 % 2.29 1.18 13.9 0.55
75 % 7.2 % 17.8 % 92.8 % 82.2 % 2.48 1.13 10.6 0.54
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found in every situation where one examines the sizes of
relative differences at different points in time or in settings
differentiated other than temporally. Observed patterns are
also influenced by the comparative sizes of the differences
between the risk distributions of advantaged and disad-
vantaged groups in the settings being examined. We might
also characterize that factor as (a) the difference in the
circumstance of the groups reflected by their outcome
rates, (b) the strength of the forces causing the groups’
outcome rates to differ, or (c) the strength of the associ-
ation between group membership and the outcome. The
purpose of examining differing outcome rates of
advantaged and disadvantaged groups is to understand
this aspect of the matter in order, for example, to deter-
mine whether forces causing outcome rates to differ have
increased or decreased over time and what factors con-
tribute to such increases or decreases. But measures of
differences between outcome rates that change solely be-
cause there occur overall changes in the prevalence of an
outcome akin to that effected by lowering a test cutoff
cannot provide useful information on such issues unless
examined with an understanding of the way the measures
tend to change solely because of changes in the preva-
lence of the outcome.
Many findings about directions of changes in the
comparative status of two groups based on some stan-
dard measure might have been broadly correct because
they were consistent with those one would reach while
accounting for the ways measures tend to change as the
prevalence of an outcome changes or were consistent
with interpretations based on a measure unaffected by
changes in prevalence of an outcome. Even then, how-
ever, such findings were misleading by implying that
the employed measures could effectively quantify the
differences in circumstances signified by the rates being
examined. This was the case with respect to the inter-
pretation of data on group differences in outcome rates
with respect to every subject where the comparative
circumstances of advantaged and disadvantaged groups
was deemed a matter of consequence and regardless of
the nature of the factors that caused those circumstances
to differ.
Though “Race and Mortality” was not my first description
of the ways the two relative differences tend to be affected by
the prevalence of an outcome, it was the most comprehensive
explication of the subject to date and appeared in a prestigious
social science magazine. And, in addition to addressing many
of the misunderstandings in the burgeoning field of health
disparities research, the article touched upon a number of
topical issues where observers commonly misinterpreted data
because they failed to understand the ways the measures they
employed tended to be affected by the prevalence of an
outcome. It was also the first substantial articulation of those
ideas in the Internet Age, when the widespread circulation of
information was far easier than ever before. “Race and Mor-
tality” thus had the potential to radically alter the way com-
mentators and scholars, as well as law enforcement officials
and courts, interpreted data on demographic differences in
rates of experiencing some favorable or adverse outcome.
Response of the National Center for Health Statistics
to “Race and Mortality”
“Race and Mortality” highlighted the Race and Health Initia-
tive, a federal program undertaken in 1998 with the intention
to spend $400 million dollars over five years to address what
were perceived to be the starkest racial disparities in health
and healthcare. In subsequent years, the funds devoted to such
research increased dramatically. In November 2000, Congress
passed the Minority Health and Health Disparities Research
and Education Act of 2000 establishing within the National
Institutes of Health (NIH) the National Center on Minority
Health and Health Disparities (NCMHD) (a center that would
eventually be raised to the status of an Institute by the Patient
Protection and Affordable Care Act of 2010). By 2003, almost
3 billion dollars yearly was being devoted to health and
healthcare disparities research, or about nine percent of the
NIH budget, while foundations and educational institutions,
as well as state and local governments, also devoted increasing
resources to such work. Since 2002, NCMHD has established
more than eighty Centers of Excellence at universities and
other institutions to develop ways to reduce health and
healthcare disparities, and programs abound to train adminis-
trators and researchers in methods for monitoring disparities.
Meanwhile, pursuant to legislation passed in 1999, commenc-
ing with fiscal year 2003, the Agency for Healthcare Research
and Quality (AHRQ) has issued yearly National Healthcare
Disparities Reports to document health and healthcare dispar-
ities and determine whether they are increasing or decreasing.
In 2011 and 2013, the Centers for Control and Prevention
(CDC) also issued extensive Health Disparities and Inequal-
ities Reports.
Thus, many billions of dollars have been devoted to the
study of health and healthcare disparities. But, while such
research has effectively shown that demographic differences
exist as to many outcomes, none of that research has consid-
ered the extent to which a particular measure used to appraise
the size of a disparity tends to be affected by the prevalence of
an outcome. Thus, efforts to determine whether such dispar-
ities have increased or decreased or what factors caused them
to do so have rarely been of value and may at times have
caused harm beyond the waste of resources and the mislead-
ing of the public and policy makers entailed in all unsound
research.
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That is not to say that measurement issues have been ignored.
In “Race and Mortality” I alluded to an exchange in 1999 in
which the Director of the National Center for Health Statistics
(NCHS) suggested that, while NCHS had not previously con-
sidered the issues I raised, it would do so in the future. But
NCHS statisticians actually responsible for developing the
agency’s approach to the measurement of health and healthcare
disparities were still unaware of those issues when I brought
“Race and Mortality” to their attention in August 2001. They
did, however, take considerable interest in the issues it raised,
and between 2004 and 2009, authored five official or unofficial
items in somemanner attempting to address those issues (Keppel
et al. 2004, 2005; Keppel and Pearcy 2005, 2006, 2009). The
most important of these was a 2005 NCHS monograph titled
“Methodological Issues in Measuring Health Disparities”
(Keppel et al. 2005), authored by the principal NCHS disparities
measurement experts and six other experts in the field.4
The monograph cited “Race and Mortality” to the effect
that determinations as to the directions of changes over time
will turn on whether one examines relative differences in
favorable outcomes or relative differences in adverse out-
comes. It illustrated the point by showing that determination
of whether the disparity between Hispanic and non-Hispanic
white women over 40 with respect to mammography in-
creased or decreased between 1990 and 1998 would turn on
whether one examined relative differences in the receipt of
mammography or relative differences in non-receipt of mam-
mography. The mammography figures cited in the document,
along with the same measures shown in Tables 1 and 2 are set
out in Table 3. But in order to simplify matters somewhat, in
Table 3 and subsequent tables I present rates only for the
outcome (favorable or adverse) typically reported, leaving
the reader to infer the rate for the opposite outcome (i.e., the
arithmetic difference between the shown rate and 100 %).
But the NCHS monograph did not discuss the implications
of the pattern by which the two relative differences tend to be
affected by the prevalence of an outcome with respect to such
pattern’s calling into question the utility of either measure for
appraising the strength of the forces causing two rates to differ
without consideration of the pattern. Rather, it merely recom-
mended that henceforth, in order to promote consistency, all
disparities (including both health and healthcare) should be
measured in terms of relative differences in adverse outcomes.
Given that the pattern whereby the two relative differences
tend to change in opposite directions as the prevalence of an
outcome changes had been almost universally unknown
among those analyzing demographic differences, it may not
be so remarkable that an institution of NCHS’s statistical
expertise would have failed to recognize such pattern until I
brought it to the agency’s attention. But once the pattern was
recognized by NCHS and those assisting it, that they could
regard the matter to be satisfactorily addressed by choosing
one relative difference over the other, and without questioning
the basic validity of either relative difference for appraising
differences in the circumstances of two groups reflected by a
pair of outcome rates, suggests a basic misunderstanding of
why one examines differences in outcome rates. Health and
healthcare disparities research largely justifies itself on the
basis that it seeks to understand the forces that cause outcome
rates to differ in order to mitigate those forces. The forces that
cause favorable outcome rates to differ are the same forces that
cause the corresponding adverse outcome rates to differ. Thus,
arbitrarily choosing a measure that says the forces have
changed in one direction over one that says the they have
changed in the opposite direction fits incongruously into a
massive governmental undertaking to address something
deemed to be a societal problem of great significance.
In any case, the perceptual consequences of the NCHS
recommendation, which would underlie Health and Human
Services’ appraisals of achievement of the health disparities
reduction goals in Healthy People 2010, are potentially sub-
stantial. A great many healthcare disparities that might previ-
ously have been deemed to be decreasing would now be
deemed to be increasing and further improvements in
healthcare would tend to be associated with increasing
healthcare disparities. Researchers at NCHS and elsewhere
who had been pondering reasonswhy disparities as to particular
types of healthcare had been decreasing now would have to
ponder reasons why disparities in the same types of care had
been increasing. That does not mean that a sound measure was
replaced with a flawed measure, but merely that a flawed
measure that tended to misleadingly indicate a pattern of de-
creasing healthcare disparities was replaced with a flawed
measure that tended to misleadingly indicate a pattern
of increasing healthcare disparities. At the same time,
the flawed measure that tended to misleadingly show
increasing disparities in adverse health outcomes like
4 These items and an internal NCHS effort to respond to “Race and
Mortality” or other articulations of its principal points are discussed on
the Consensus subpage of the Scanlan’s Rule page.
Table 3 White and Hispanic mammography rates in 1990 and 1998, with measures of difference
Year White mamm rate Hispanic mamm rate W/H ratio mamm H/W ratio no mamm Percentage point diff EES
1990 52.7 % 45.2 % 1.17 1.16 7.5 0.19
1998 68.0 % 60.2 % 1.13 1.24 7.8 0.21
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morbidity and mortality during periods of general im-
provements in health was left in place.
But NCHS’s treatment of the matter, either in the 2005
monograph or elsewhere, has done little to make it widely
known that the two relative differences may change in oppo-
site direction or even to make it clear that NCHS measures all
disparities in terms or relative differences in adverse out-
comes. Though Healthy People 2010 measured all disparities
in terms of relative differences in adverse outcomes, it de-
scribed many healthcare disparities in terms of favorable
outcomes. Only those who read the Technical Appendix will
recognize, for example, that the relative differences reported
for a favorable outcome like immunization is actually the
relative difference for the corresponding adverse outcome,
and only those who read the references cited in the Technical
Appendix will appreciate that what is reported as an increase
in the relative difference for some favorable outcome may in
fact involve a decrease in that relative difference. And only
those who read the references in those references are likely to
appreciate that neither relative difference is providing useful
information about the nation’s progress in addressing differ-
ences in the health- and healthcare-related circumstances of
advantaged and disadvantaged groups.5 Various articles or
presentations by NCHS personnel have contributed to the
failure of understanding by commonly discussing disparities
measurement issues, including nuances of those issues, with-
out mention even of the possibility for the two relative differ-
ences to change in opposite directions (Keppel 2007; Keppel
et al. 2007; Klein and Huang 2010).
The Agency for Healthcare Research and Quality (AHRQ)
which publishes the yearly National Healthcare Disparities
Report (NHDR), has yet to show a recognition that it is
possible for the two relative differences to change in opposite
directions or that any measure of differences between outcome
rates tends to be systematically affected by the prevalence of
an outcome.6 The same may be said of the Institute of Med-
icine of the National Academy of Sciences, which provides
occasional guidance for the NHDR and issues its own reports
on progress in reducing healthcare disparities.
AHRQ also funds a great deal of health and healthcare
disparities research. But it is virtually certain that AHRQ
officials making funding decision, like those seeking the
funding, do so without any understanding of the ways the
measures to be employed in the research are likely to be
affected by the prevalence of the outcomes at issue. Exemplary
of the process is a $10 million AHRQ contract with the
Institute for Medicine and Public Health of the Vanderbilt
University Medical Center aimed at evaluating the effective-
ness of quality improvement in reducing disparities in health
and healthcare. The contract yielded a 475-page, peer reviewed
report, issued in August 2012, that cites 4258 sources that were
examined in fulfillment of the contract. But the report reflects
no recognition whatever of the way the various measures
employed in those studies may be affected by the prevalence
of an outcome or even that it is possible that various measures
could yield different conclusions as to directions of changes in
disparities. In discussing findings of various studies, the report
does not identify the measures that were used.7
The Centers for Disease Control and Prevention (CDC), of
which NCHS is a part, conducts a substantial amount of
healthcare disparities research, particularly with regard to im-
munization, even apart from the previously mentioned 2011
and 2013 Health Inequalities and Disparities Reports. The
reports, like the many studies CDC researchers have conducted
of immunization disparities, mainly rely on absolute differences
between rates as a measure of disparities (a subject discussed
below), though in some instances also showing relative differ-
ences in adverse or favorable outcomes. To my knowledge, no
CDC document (save in the sense that NCHS is part of CDC)
has ever indicated that it is possible for the two relative differ-
ences to change in opposite directions, that any measure tends
to change solely because the prevalence of an outcome chang-
es, or that there exist situations where NCHS would reach
different conclusions about the direction of changes in dispar-
ities from those CDC would reach. In a 2013 videocast on
healthcare disparities, a CDC official discussing what the agen-
cy regards as great progress in reducing childhood immuniza-
tion disparities observed that once rates reached the 95 % level
there was little room for disparities. Meanwhile, a NCHS study
(Keppel 2007) found the largest black-white healthcare dispar-
ity to be in the failure to have an ongoing source of care where
the black and white rates of having such a source were 93.5 %
and 96.9%. In other words, CDC can find healthcare disparities
to be negligible in essentially the same circumstances where its
arm NCHS finds disparities to be greatest.
Some private researchers have been measuring healthcare
disparities in terms of relative differences in adverse out-
comes, with or without reference to the NCHS recommenda-
tion, and with or without employing the approach of describ-
ing the matter in favorable terms while analyzing the matter in
adverse terms. Notable is 2009 study in Cancer Epidemiology
Biomarkers and Prevention by Harper et al. that examined
mammography disparities over a period when mammography
5 See slide titled “Healthy People 2010 Technical Appendix at A-18” in
the FCSM presentation referenced in note 2.
6 In the NHDR, AHRQ attempts, consistent with the NCHSHealthy People
guidance, to measure disparities in terms of relative difference in adverse
outcomes evenwhen the report describes the subject in terms of the favorable
outcome. But it has not been invariably successful in doing so. In the 2012
report, among the situations highlighted as involving the most rapidly
decreasing disparities are situations where relative differences in adverse
outcomes in fact increased though relative differences in the corresponding
favorable outcomes decreased. See Table 5 of the FCSMpresentation and the
NHDR Measurement subpage of the Measuring Health Disparities page.
7 See the AHRQ’s Vanderbilt Study subpage of the Measuring Health
Disparities page.
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use had increased substantially. The abstract noted that “area-
socioeconomic disparities in mammography use increased by
161 %.” But that figure actually was for the change in relative
differences in non-receipt of mammography. As commonly
happens during periods of substantial general increases in
mammography (or anything else), relative differences in re-
ceipt of the procedure decreased substantially.8
The fact that the NCHS recommendation is not universally
followed, and may not even be widely known, among dispar-
ities researchers is reflected in an award winning study
appearing in Pediatrics in 2008. Relying on relative differ-
ences in vaccination rates as a measure of disparity, Morita
et al. found that a school-entry Hepatitis B vaccination re-
quirement that dramatically increased overall vaccination
rates also dramatically reduced racial and ethnic vaccination
disparities. As shown in Table 4, which presents figures from
the Morita study on black and white fifth and ninth graders,
NCHS would have found dramatically increased disparities
(while those like CDC that rely on absolute differences would
have found increasing disparities for fifth graders and decreas-
ing disparities for ninth graders, in accordance with the pattern
discussed below).
But rarely when an outcome increases from being very
uncommon to being very common, as occurred in the case of
the type of immunization that was the subject of the Morita
study, will one fail to find a dramatic decrease in relative
differences between rates of experiencing the outcome and a
dramatic increase in rates of failing to experience the outcome.
I have yet, however, to see any study of immunization dispar-
ities recognize the implications of whether one examines rela-
tive differences in receipt of immunization or non-receipt of
immunization, even in studies that rely on both measures.9
And notwithstanding the NCHS treatment of the matter in
2005, rarely will one find recognition that there exist two
relative differences or that it is even possible for them to yield
different conclusions as to the directions of changes over time.
Particularly in the discussion of racial disparities in cancer
outcomes, studies commonly refer to relative differences in
survival and mortality interchangeably, often stating that they
are examining survival differences, while in fact examining
mortality differences. Invariably, they do so without recogniz-
ing that as survival generally increases, relative differences in
survival tend to decrease while relative differences in mortal-
ity tend to increase, or that more survivable cancers tend to
show smaller relative differences in survival but larger relative
differences in mortality than less survivable cancers. Indeed, it
is likely that most reports about the comparative size of cancer
survival disparities by type of cancer or age group are in fact
reports about relative differences in mortality and involve
situations where the comparative size of the relative differ-
ences in survival is the opposite of that reported.10
While my focus here is principally upon the situation in the
United States, it warrants note that there is little reason to
expect other countries to follow, or even know about, the
NCHS recommendation to measure all healthcare disparities
in terms of relative differences in adverse outcomes. Thus,
healthcare researchers in other countries will commonly reach
opposite conclusions about the comparative size of disparities
from those NCHS would reach. While citing the NCHS 2005
monograph, a 2013 World Health Organization Handbook on
Health Inequality Monitoring measures healthcare disparities
in terms of relative differences in favorable outcomes. And,
for example, it reaches starkly different conclusions about the
comparative size of socioeconomic disparities in attendance of
a skilled person at birth in different countries from those
NCHS would reach on the basis of relative differences in the
absence of such attendance.11
Many guides to the measurement of health and health
disparities have been produced in the United States and abroad
since 2000, including a popular University ofMichigan online
guide (Lynch and Harper 2005), guides from the National
Cancer Institute (Harper and Lynch 2006, 2007), and a recent
document from Harvard Medical School and Massachusetts
General Hospital (Weissman et al. 2011), which will receive
further attention below. But, apart from a 2005 guide issued by
8 See Table 13 of the FCSM presentation.
Table 4 White and black Hepatitis B vaccination rates in grades 5 and 9 before and after imposition of school-entry vaccination requirement, with
measures of difference
Grade Year Program White vac rate Black vac rate B/W ratio no vac W/B ratio vac Percentage point diff EES
5 1996 Pre 8 % 3 % 1.05 2.67 5 0.47
5 1997 Post 46 % 33 % 1.24 1.39 13 0.34
9 1996 Pre 46 % 32 % 1.26 1.44 14 0.37
9 1997 Post 89 % 84 % 1.45 1.06 5 0.24
9 See discussion in the Immunization Disparities page of a study that
examined both relative differences in favorable outcomes (with respect to
receipt of full immunization) and relative differences in adverse outcomes
(with respect to failure to receive any immunization), but without recog-
nizing that general increases in immunization would tend to reduce the
first relative difference while increasing the latter relative difference.
10 See the Mortality and Survival page and the Mortality/Survival Illus-
trations subpage of the Scanlan’s Rule page, as well as Table 12 of the
FCSM presentation.
11 See Table 5 of the FCSM paper.
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a Public Health Observatory in the United Kingdom (Carr-
Hill and Chalmers-Dixon 2005),12 the NCHS responses to
“Race and Mortality” is the only guide reflecting the least
understanding of the ways measures tend to be affected by the
prevalence of an outcome.
Absolute Differences and the Value Judgment Fallacy
In 2000 absolute differences between rates did not seem to be
used often enough in the measurement of health disparities or
other demographic differences to warrant attention in “Race
and Mortality,” which, in any case, focused on common
misunderstandings of the two relative differences. Since that
time, however, the use of absolute differences to appraise
demographic differences has increased considerably, particu-
larly in analyses of racial/ethnic and socioeconomic disparities
in healthcare.
The absolute difference between rates – in the test score
hypothetical, 17 percentage points before and 8 percentage
points after the cutoff was lowered – is unaffected by whether
one examines the favorable or the adverse outcome. Hence,
such measure will yield only one conclusion as to the com-
parative size of disparities in different settings. But, as sug-
gested earlier, for a measure to usefully quantify the difference
in the circumstances of two groups reflected by a pair of
outcome rates the measure must remain constant when there
occurs a change in overall prevalence akin to that effected by
the lowering of a test cutoff. And, like the two relative differ-
ences, absolute differences tend to be systematically affected
by the overall prevalence of an outcome, though in a more
complicated way than the two relative differences. Roughly,
as uncommon outcomes (below 50 % for both groups) be-
come more common, absolute differences between rates tend
to increase; as common outcomes (above 50 % for both
groups) become even more common, absolute differences
tend to decrease. The prevalence-related direction of change
is harder to predict when the outcome is neither common nor
uncommon or changes from being uncommon to common (or
vice-versa) during a period examined.13
As I discuss further in the section on pay-for-performance,
in the main, observers relying on absolute differences have
tended to do so without mention that a relative difference
could (or in fact would in the particular circumstances exam-
ined) yield an opposite conclusion about the comparative size
of a disparity from that yielded by the absolute difference.
That holds even when the relative difference yielding a con-
trary conclusion is the measure typically employed in the
circumstances. But in recent years there has been increasing
recognition of the importance of presenting both relative and
absolute differences in reporting on health and healthcare
disparities (King et al. 2012; Welch et al. 2012). In circum-
stances where the particular relative difference the observer
happens to be examining yields a different conclusion about
the comparative size of two disparities from that yielded by
the absolute difference, it has been argued that the contrasting
conclusions are both valid in their way and that observers must
make a value judgment in choosing between them (Lynch and
Harper 2005; Harper et al. 2010). So far such discussions have
entirely ignored the existence of a second relative difference.
They have done so, even though, irrespective of the patterns I
describe here, anytime it is noted that a relative difference and
the absolute difference yield different conclusions about the
comparative size of two disparities, the unmentioned relative
difference necessarily will yield a conclusion that is the oppo-
site of that yielded by the mentioned relative difference and the
same as that yielded by the absolute difference.14
But consideration of the notion that two measures yielding
opposite conclusions about such things as whether a disparity
has increased or decreased over time could both be in some
way valid, or that one must employ a value judgment to chose
between them, provides a useful focal point for demonstrating
12 The handbook (at 172) recognized that the patterns of contrasting
changes in the two relative differences were functions of the underlying
distributions, a recognition not reflected in the NCHS documents.
13 Certain nuances of the pattern by which absolute differences tend to
change as the prevalence of an outcome changes are discussed in the
introductory section of the Scanlan’s Rule page.
14 The two relative differences and the absolute difference may all change
in the same direction as the prevalence of an outcome changes, in which
case one can infer that there occurred a true change in the strength of the
forces causing the two groups’ rates to differ. But in the more common
circumstanceswhere all measures do not change in the same direction, the
absolute difference will change in the same direction as the smaller
relative difference.
Table 5 Hypothetical hire rates of advantaged and disadvantage groups, with measures of difference
Employer AG hire rate DG hire rate AG/DG ratio hire DG/AG ratio rejection Percentage point diff Odds ratio
A 20.0 % 9.0 % 2.22 (1) 1.14 (4) 11.0 (4) 2.53 (1)
B 40.0 % 22.6 % 1.77 (2) 1.29 (3) 17.4 (2) 2.28 (3)
C 70.0 % 51.0 % 1.37 (3) 1.63 (2) 19.0 (1) 2.24 (4)
D 80.0 % 63.4 % 1.26 (4) 1.83 (1) 16.6 (3) 2.31 (2)
Soc (2014) 51:328–346 335
a number of things about differing outcome rates of advantaged
and disadvantaged groups and what we can learn from them.
Table 5 presents four situations that we might initially
regard as the hiring patterns of four employers who hire for
similar jobs from the same labor market and where we are
required to rank the employers in descending order of the
likelihood that theymade biased hiring decisions or the degree
of bias in those decisions. The principles I intend to elucidate,
however, would apply equally in a range of circumstances
where one might wish to compare the size of selection or
rejection disparities, including with respect to changes in the
disparities over time or differences in the sizes of the dispar-
ities as to different types of jobs or as to candidates of differing
qualification levels. I will refer to this table again in subse-
quent discussion of such things as the misguided inclusion of
healthcare disparity measures as performance elements in pay-
for-performance programs.
The columns following the hire rates contain the same three
measures of differences between selection or rejection rates
used in the earlier tables, as well as the ratio of AG’s odds of
selection to DG’s odds of selection.15 The parenthetical num-
bers reflect rankings of the comparative likelihood of bias (or
degree of bias), from greatest to smallest, according to the
particular measure.
Those who measure disparities in terms of relative
differences in favorable outcomes (as would commonly
be done in an employment discrimination case involving
hiring or promotion) would rank the employers A,B,C,D.
Those who measure disparities in terms of relative differ-
ences in adverse outcomes (as would commonly be done
in a lending discrimination case or in an investigation of
disparities in school discipline, and as might also be done
in an employment discrimination case where the favorable
outcome is retention and the adverse outcome is termina-
tion) would rank them D,C,B,A, the opposite of the first
approach. Those who measure disparities in terms of
absolute difference between rates (as has been done in
studies of lending disparities by the Federal Reserve
Board and as is increasingly done in studies of public
school proficiency disparities and healthcare disparities)
would rank them C,B,D,A. Those who measure disparities
in terms of odds ratios (as often would be done by those
attempting to adjust for differences in characteristics by
means of logistic regression) would rank them A,D,B,C,
the opposite of the ranking according to the absolute
difference.
I suggest, however, that would be manifestly absurd to
maintain that one employer is more likely to be biased
than another as to selection while the other is more likely
to be biased as to rejection. It would be likewise absurd to
say that contrasting interpretations as to likelihood of bias
based on either of the two relative differences and the
absolute difference (or odds ratio) could all be sound or
that determining which employers are the more likely to
be biased involves a value judgment. Rather, there can
exist only one reality as to the comparative likelihood of
bias of the employers reflected in the data, even though
that reality may be difficult to divine. The same holds for
the above-mentioned alternative formulations of the hy-
pothetical in a hiring context, as it would in any other
context where bias might be involved in the allocation of
favorable and adverse outcomes among different demo-
graphic groups.
That there can be only one reality may be most evident
when something like biased decision-making is at issue. But it
is no less the case when the questions of concern are whether
the forces causing health or healthcare outcome rates of
advantaged and disadvantaged groups to differ have increased
or decreased over time and whether the policies or persons
responsible for the changes should be regarded with approval
or disapproval. For, as with selection and rejection, the forces
causing rates for any favorable outcome to differ are the same
forces causing rates for the corresponding adverse outcome to
differ.
What then would be the soundest ranking of the employers
with regard to the likelihood or degree of bias in its hiring
decisions? Each row of information is based on the specifica-
tions underlying the test score hypothetical at the outset – that
is, normal risk distributions with means that differ by half a
standard deviation. There thus is no rational basis for asserting
that the strength of the forces causing the observed differences
in hire (or rejection) rates to differ varies among any of the
four situations reflected in the table, and any measure that
suggests the strength of those forces does vary from situation
to situation is a flawed measure.
ATheoretically Sound Measure of the Forces Reflected
by a Pair of Outcome Rates
Implicit in the illustration in Table 5 is that the only theoret-
ically sound way to appraise the strength of the forces causing
favorable or adverse outcome rates of advantaged and disad-
vantaged groups to differ is to derive from pairs of outcome
rates the difference between the means of the underlying
distributions of factors associated with experiencing the
15 The odds of selection for each group is the group’s selection rate
divided by its rejection rate. As the prevalence of an outcome changes,
the difference measured by the odds ratio tends to change in the opposite
direction of the absolute difference. In order to lessen the complexity of
this article I give the odds ratio only limited attention. But of the four
standard measures discussed here, the odds ratio changes the least as the
overall prevalence of an outcome changes and yields interpretations more
closely approximating interpretations based on a theoretically sound
measure than any of the other measures (as illustrated, for example, in
Tables 3 and 4 of the Subgroup Effects subpage of the Scanlan’s Rule
page).
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outcome at issue. I have commonly termed the figure so
derived the estimated effect size (EES).16 The selection or
failure rates in Table 5 by definition would yield an EES of
0.5 standard deviations, which would mean that approximate-
ly 31 % of the disadvantaged group’s distribution is above the
mean for the advantaged group.17
This approach to appraising the strength of the forces
causing outcome rates to differ is inexact in a number of
respects. For example, it relies on an assumption that the
underlying distributions of factors associated with experienc-
ing an outcome are normal. Rarely can we be sure that the
underlying distributions are normal and sometimes we will
know that they are not normal, as, for example, when the
distributions are truncated part of normal distributions. There
also exists a range of more subtle issues.18 But an approach of
this nature (including any that might be better informed as to
actual shapes of the underlying risk distributions) is plainly
superior to reliance on standard measures of differences be-
tween outcome rates without consideration of the ways the
measures tend to be affected by the prevalence of the outcome
at issue. For it provides a benchmark for appraising the
strength of the association reflected by any pair of rates and
for comparing the strengths of association reflected by two or
more pairs of rates when standard measures would yield
varying interpretations as to the comparative size of the differ-
ences between rates. And it can at least spare us from wrongly
concluding, on the basis of one preferred standard measure or
another, that there is reason to distinguish among the em-
ployers in Table 5 and then mistakenly devoting resources to
exploring the reasons for the perceived differences, drawing
inference based on the perceived differences, or making deci-
sions of consequence based on the perceived differences.
The EES figures in Tables 2 through 4 provide us some
perspective on the measure, with respect to both how we
might regard the size of the particular disparity and what
conclusions we might draw about changes over time. Table 2
indicates that differences in susceptibility to poverty are slight-
ly larger than the above-described differences reflected by the
hypothetical test score data. Given that the table reflects the
consequences solely of changes in prevalence of poverty, that
the EES figures change at all from row to row indicates an
imperfection in the method in consequence of minor irregu-
larities in the two distributions. But that the differences are
minimal relative to in the size of the EES figures reflects the
utility of the measure for estimating whether during times of
changes in overall poverty, there occurred any meaningful
change in the differences between the circumstances of
advantaged and disadvantaged groups pertinent to likelihood
of being in or out of poverty.
The EES figures in Table 3 for the Hispanic-white disparity
in mammography suggest a rather smaller disparity than ob-
served for the black-white difference in susceptibility to pov-
erty. And while the EES increased slightly over the course of
the period examined, the size of the change was such as to
offer little reason to believe anything meaningful occurred
regarding the strength of the forces causing Hispanic and
white mammography rates to differ.
The EES figures in Table 4 suggest that the differences in
black-white likelihood of Hepatitis B immunization, both
before and after imposition of the vaccination requirement,
are somewhere between the difference in black-white suscep-
tibility to poverty reflected in Table 2 and the difference in
Hispanic-white mammography reflected in Table 3. But the
figures also indicate that the imposition of the vaccination
requirement in fact caused the strength of the forces causing
rates to differ (differences in the circumstances of the two
groups) to noticeably decrease. That is something that it
would seem reasonable to expect when a school-entry require-
ment is imposed. A rigidly enforced requirement should en-
tirely eliminate any disparity. Further perspective on the EES
figure is provided in tables discussed below.
Absolute Differences and Pay-for-Performance
Most adverse health outcomes are in ranges where reductions
in those outcomes tend to reduce absolute differences between
rates of advantaged and disadvantaged groups. Were re-
searchers to employ absolute differences to appraise things
like racial differences in infant mortality, the common percep-
tion that demographic differences in such outcomes have been
increasing would change to a perception that they have been
decreasing. Recent reliance on absolute differences as a mea-
sure of healthcare disparity involves outcomes that can be in
ranges where improvements will tend either to increase or
reduce absolute differences. An illustration of the
prevalence-related patterns may be found in Table 5, if one
considers Rows A and B to reflect the before and after situa-
tions for an increase in an uncommon healthcare outcome and
Rows C and D to reflect the before and after situations for an
increase in a common healthcare outcome. The standard pat-
tern of declining relative differences for the increasing out-
come and increasing relative differences for the corresponding
decreasing outcome exists in both situations. But the absolute
16 After much thought on whether one could soundly measure health
disparities, I developed this method in late 2007. But in 2010 I came to
recognize that the method has been in existence since 1934 in what is
known as the probit. See the Solutions subpage of the Measuring Health
Disparities page.
17 Table 2 of the FCSM presentation shows for a variety of pairs of rates
the EES and meaning of the EES in terms of the proportion of the
disadvantaged group’s distribution that is above the mean of the
advantaged group’s distribution.
18 For a fuller explanation of the problems with the described approach,
see the Solutions, Irreducible Minimums, and Cohort Considerations
subpages of the Measuring Health Disparities page and the Truncation
Issues subpage of the Scanlan’s Rule page.
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difference increases in the former situation and decreases in
the latter.
An instructive example of the failure to understand the
ways absolute differences tend to be affected by the preva-
lence of an outcome may be found in two studies appearing in
the same 2005 issue of the New England Journal of Medicine.
Jha et al. relied on absolute differences between rates in exam-
ining racial disparities in rates of receiving certain fairly un-
common procedures where rates were generally increasing;
and, as commonly happens when outcome rates in the ranges
at issue are generally increasing, the absolute differences be-
tween rates usually increased. Trivedi et al. relied on absolute
differences between rates in examining racial disparities in
adequacy of care (including both treatment and control of
conditions) where adequacy of care rates (especially as to
treatment) were at generally high levels and increasing; and,
as commonly happens in such circumstances, absolute differ-
ence between rates usually decreased (especially for treatment).
But neither study, nor a commentary discussing the con-
trasting findings (Lurie 2005), recognized that absolute differ-
ences tend generally to behave in the manner observed in each
study irrespective of any changes in the forces causing rates of
racial groups to differ. The same situation holds for all other
efforts to date that have relied on absolute differences to
determine whether healthcare disparities have increased or
decreased over time or are larger in one setting than another
(e.g., managed care versus fee-for-service care, as in
Schneider et al. 2001) or with respect to one type of outcome
compared with another (e.g., treatment of conditions versus
control of conditions, as in Trivedi et al. 2006).
All research that relies on some measure without consider-
ation of the way it is affected by the prevalence of an outcome
wastes resources and misleads those who rely on it. But it is
with respect to reliance on absolute differences in healthcare
outcome rates in the pay-for-performance (P4P) context that
the failure to understand the waysmeasures tend to be affected
by the prevalence of an outcome may have the most concrete
adverse consequences.
A 2005 study in Circulation by Werner et al. relied on
absolute differences between rates in finding that a coronary
artery bypass graft (CABG) report card program, which was
believed to generally increase CABG rates, increased racial
differences in such rates. The white rate had risen from 3.6 %
to 8.0 % while the black rate had risen from 0.9 % to 3.0 %,
with a resulting increase in the absolute difference from 2.7
percentage points to 5.0 percentage points. As discussed
above, such rates are in ranges where general increases would
commonly increase absolute differences without regard to any
change in the strength of the forces causing rates of
advantaged and disadvantaged group to differ.
These figures are set out in Table 6, along with the rate
ratios for receipt and non-receipt of CABG and the EES. In
addition to showing the increase in the absolute difference for
this uncommon outcome, the table shows that the relative
difference in receipt of the procedure decreased, while the
relative difference in failure to receive the procedure (the
NCHS approach) increased. In other words, each measure
behaved in accordance with the prevalence-related patterns
described above. The EES suggests that they did so even
though, to the extent that the forces causing white and black
rates to differ can be measured, such forces decreased.
But without consideration of the prevalence-related pat-
terns – or the fact there had occurred a decrease in the relative
difference in the favorable outcome, which was probably the
most common measure of such disparities at the time – the
authors interpreted the increase in absolute differences to
indicate that incentive programs would tend to increase
healthcare disparities. Observers then uncritically employed
the same reasoning to conclude from the study that the P4P
programs being implemented across the county would tend to
increase racial disparities in healthcare. In order to counter that
tendency, they recommended that P4P programs include
criteria for evaluating provider performance on the basis of
the size of, or changes in the size of, healthcare disparities.
Massachusetts responded to that recommendation by includ-
ing a healthcare disparities criterion in its Medicaid P4P
program, and it employed a measure of disparity that is a
function of the absolute difference.
Any P4P program tying performance to some measure of
disparity without consideration of the way the measure tends
to be affected by the overall prevalence of an outcome would
involve allocation of monetary incentives for reasons unrelat-
ed to the comparative equity at monitored institutions. And
that would hold regardless of the measure used.
In cases where programs measure disparities in terms of
changes in absolute differences over time, as noted several
paragraphs above, improvements in healthcare for uncommon
outcomes will tend to be perceived as increasing disparities,
while improvements for common outcomes will tend to be
perceived as reducing disparities. In rate comparisons across
Table 6 CABG rates of white and blacks before and after use of CABG report card, with measures of difference
Period White CABG rate Black CABG rate W/B ratio CABG B/W ratio no CABG Percentage point diff EES
Before 3.6 % 0.90 % 4.00 1.03 2.7 0.57
After 8.0 % 3.00 % 2.67 1.05 5.0 0.48
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hospitals, higher-performing hospitals will tend to show larger
disparities than lower-performing hospitals for uncommon
outcomes but smaller disparities for common outcomes (as
again reflected in Table 5 where rows A and B represent the
lower-performing and higher-performing hospitals as to un-
common outcomes and Rows C and D represent such hospi-
tals as to common outcomes). The Massachusetts program
appraised disparities across hospitals and did so with respect
to meeting some recommended standard of care where rates
averaged above 80 % for all groups. Given the tendency for
higher overall rates in such ranges to be associated with
smaller absolute differences, the program will tend to find
healthcare disparities to be smaller at higher-performing hos-
pitals than lower-performing hospitals. It thus will tend to
reward higher-performing hospitals for reasons unrelated to
a useful indicator of cross-hospital equity. Further, since
higher-performing hospitals tend to have smaller minority
representations among their patient populations than lower-
performing hospitals, the inclusion of a disparities criterion in
the Massachusetts P4P program, by diverting resources away
from providers with large numbers of minority patients, is
more likely to increase healthcare disparities than to reduce
them.19
Meanwhile, in the United Kingdom, reliance on absolute
differences to measure healthcare disparities with respect to a
fairly common outcome, where improvements tend to reduce
absolute differences, has led to the perception in that country
that P4P will tend to reduce healthcare disparities. UK re-
searchers tend also to rely on absolute differences between
rates to measure socioeconomic differences in cancer out-
comes. Thus, in contrast to the research in the United States,
which, as discussed, measures cancer outcome disparities in
terms or relative differences in mortality (while terming them
relative differences in survival) and tends to find increases in
survival to be associated with increasing racial disparities,
research in the UK tends to find general improvements in
survival to be associated with increasing disparities for less
survivable cancers and decreasing disparities for more surviv-
able cancers.
Illogical Expectations and Unfounded Inferences
In “Race and Mortality” I explained that implicit in the de-
scribed pattern by which the two relative differences are
affected by the prevalence of an outcome is a pattern whereby,
when an outcome changes in prevalence, the group with the
lower baseline rate will tend to experience a larger proportion-
ate change in its rate of experiencing the outcome while the
other group will tend to experience a larger proportionate
change in its rate of experiencing the opposite outcome. For
example, the hypothetical lowering of a test cutoff shown in
Table 1 caused the failure rate of AG to decrease by 75 %
compared with a 65 % reduction for DG, while causing the
pass rate of DG to increase by 38 % compared with a 19 %
increase for AG.
Yet it is commonly assumed that whenever something
causes outcome rates to change it is somehow normal for
different baseline rates to change the same proportionate
amount and that something significant must have occurred
whenever those rates are found to change by different propor-
tionate amounts. Irrespective of the statistical pattern de-
scribed above, however, the expectation of equal proportion-
ate changes is illogical. For a factor cannot cause equal pro-
portionate changes in two different baseline rates for
experiencing some outcome while causing equal proportion-
ate changes in the opposite outcome rates. That is, if a factor
were to cause baseline rates of 20 % and 10 % to change
equal proportionate amounts (say, doubling them to 40 %
and 20 %), it will necessarily cause the opposite outcome
rates to change different proportionate amounts (80 % re-
duced to 60 %, a 25 % reduction; 90 % reduced to 80 %, an
11 % reduction). Since there is no more reason to expect
equal proportionate changes in one outcome than there is to
expect equal proportionate changes in the opposite out-
come, there is no reason to regard it as somehow normal to
find equal proportionate changes in either outcome.
Nevertheless, when advances in healthcare cause larger
proportionate reductions in adverse health outcomes among
advantaged groups than disadvantaged groups, observers de-
vise seemingly sophisticated theories to explain those pat-
terns, such as the “diffusion of innovation” or the ‘inverse
equity” hypotheses. But they devise these theories without
consideration that the disadvantaged group has experienced
the larger proportionate increase in the favorable outcome.
Similarly, in an increasingly common area of study called
“reporting heterogeneity” observers find significance, for ex-
ample, in the fact that a chronic health condition causes a
larger proportionate increase in the reporting of less-than-
good health among advantaged groups than disadvantaged
groups and theories are posited as to what such pattern sig-
nifies. But the same studies would commonly show that such
conditions reduce rates of good-or-better health proportion-
ately more among disadvantaged than advantaged groups.
For as long as demographic differences in poverty have
been studied observers have been reporting as if it were
significant that poverty has increased or decreased proportion-
ately more among advantaged groups than disadvantaged
groups. But, as suggested by Table 2, when there occurs any
substantial change in poverty, rarely will one fail to find that
the poverty rates of groups with lower baseline rates changed
proportionately more than other groups or that the other
19 See the Pay for Performance and Between-Group Variance subpages of
the Measuring Health Disparities page and pages 21 to 24 of the letter to
Harvard University discussed infra.
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groups experienced larger proportionate changes in rates of
avoiding poverty. That female-headed families experiencing a
smaller proportionate decline in poverty than other groups
during the substantial reductions in poverty between 1959
and the early 1970s was an important element in perceptions
about the “feminization of poverty” – a misguided concept
given several paragraphs in “Race and Mortality,” and refer-
enced in note 3 above, but one as vibrant and misunderstood
in 2014 as in 2000. Lately, however, researchers have been
discussing the comparative size of percentage point changes
in poverty, an approach that would have found female-headed
families to have especially benefited from reductions in pov-
erty half a century ago. Whatever the measure employed,
however, poverty researchers have yet to address the extent
to which observed patterns are functions of overall changes in
poverty.
In clinical trials substantial resources are devoted to deter-
mining whether an intervention will cause different propor-
tionate changes in the baseline rates of different subgroups (a
phenomenon termed “subgroup effects,” “effect heterogene-
ity,” “interaction,” etc.) and there occurs frequent discussion
about methods for determining whether observed differences
in proportionate changes might merely reflect sampling vari-
ability rather than differences that exist in the population at
large. Institutions providing guidance on evidence-basedmed-
icine commonly recommend that, absent sound evidence of a
subgroup effect, as defined above, treatment decisions shall be
based on the assumption that, for example, a factor that is
observed to reduce a baseline rate of 20 % to 10 % in a
clinical trial will cause a like 50% reduction of all other baseline
rates. Few question the soundness of this assumption.20
In “Race and Mortality” I discussed a number of situations
where observers drew inferences based on the size of relative
differences in a favorable or adverse outcome in some sub-
population without consideration of the role of the compara-
tively high or low prevalence of the outcome within the
subpopulation. Usually these involved attention to a seeming-
ly large relative difference in some adverse outcome within an
advantaged subpopulation where the outcome tended to be
rare, such as comparatively large racial differences in infant
mortality where parents were highly-educated or comparative-
ly large racial differences in rejection rates among high-
income mortgage loan applicants. Another prominent exam-
ple may be found in interpretations of occupational differ-
ences in the health of British civil servants in what are known
as the Whitehall Studies. Such studies have found larger
relative differences in adverse health outcomes in this rela-
tively advantaged subpopulation, few of whose members
suffered any material deprivation, than in the general UK
population. The steeper gradient among civil servants than
the general population has been interpreted as suggesting that
differences in psychosocial factors and stresses arising from
the workplace hierarchy are as important to health disparities
as differences in material well-being, or that observed relative
differences in adverse outcomes among the general population
are smaller than would be observed if there existed indicators
of socioeconomic status for the general population that are as
precise as the occupational categories at Whitehall. Those
drawing such inferences, however, have failed to consider that
large relative differences in adverse outcomes are to be ex-
pected among British civil servants simply because they are a
relatively healthy subpopulation or that relative differences in
favorable outcomes are likely to be smaller among civil ser-
vants than the general UK population.
Similarly, researchers have noted the diminishing relative
differences in adverse health outcomes among Whitehall re-
tirees, opining that the removal from the stresses of a hierar-
chical working environment are the reason for the reduction in
the disparity (Chandola et al. 2007). But, as in the common
situation where one observes smaller relative differences in
mortality (though larger relative differences in survival)
among the old than the young, there is no basis for drawing
any inferences based on a comparison of relative differences
(as to either outcome) without consideration of the effects of
prevalence on the chosen relative difference.21
Inferences based on the comparative size of relative differ-
ences in favorable outcomes are no less problematic than
those based on the comparative size of relative differences in
adverse outcomes. In the employment context, some ob-
servers would read smaller relative differences in selection
rates among more credentialed applicants, where selections
rates tend to be high (as in Rows C and D of Table 4), than
among less-credentialed applicants, where selection rates tend
to be low (as in Rows A and B), as indicating that employers
are less inclined to rely on stereotypes when there exist ob-
jective indicators of qualifications. They draw that inference,
however, unaware or ignoring that examination of relative
differences in rejection rates would support an opposite infer-
ence. The mistaken interpretation of comparatively larger
racial differences in mortgage rejection rates among high-
income applicants discussed in “Race and Mortality” could
just as well have been couched in terms that having higher20 Issues concerning the interpretation of subgroup effects, as well as
issues pertaining to the manner in which a risk reduction observed in a
clinical trial should be used to estimate the absolute risk reduction and
number-needed-to-treat to avoid one adverse event in circumstances
involving different baseline rates from that in the clinical trial, have great
practical importance. But the treatment of such issues to date suffers from
the same shortcomings as health disparities research. See the Subgroup
Effects subpage of the Scanlan’s Rule page.
21 The United Kingdom has long been the leader in health disparities
research and the Whitehall Studies have been a cornerstone of the
research. But such research has never been any sounder in the UK than
elsewhere. See my British Society for Population Studies 2006 Confer-
ence paper titled “The Misinterpretation of Health Inequalities in the
United Kingdom.”
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income does not reduce chances of rejection as much for
blacks as whites. But one study (Kim and Squires 1995)
instead examined the effects of having higher income on
mortgage approval rates of blacks and whites, finding that
the increase in approval rates was greater for blacks than
whites, and posited an explanation for that pattern. Whether
or not the explanation was plausible, it lacked a statistical
foundation.
Focusing on the negative factor of having a criminal record
on the favorable outcome of receiving callback after a job
interview for tester pairs comprised of two black or two white
job applicants, a study (Pager 2003) finding that having a
criminal record reduced callback rates proportionately more
for blacks than whites posited an explanation for that pattern.
Overlooked, however, was that the criminal record increased
the rates of failure to receive a callback more for whites than
blacks. The latter difference, which is the one NCHS would
examine, would have required a different explanation. Data
from the study are presented in Table 7.
In this case, however, the measures of difference show the
effect of a factor on blacks and whites rather than the effect of
race. The table shows that the standard measures all behave in
the way the prevalence-related forces typically would drive
them. And the EES, which is also suitable for this purpose,
indicates that the effect of having a criminal record was
essentially the same for blacks and whites.22
An interesting thing about a study of this nature (also
pertinent to any study where overall favorable outcome rates
can be very low or very high) is that if the job market or the
fabricated qualification of the tester pairs were such as to make
chances of callback very high, there would be a tendency to
examine relative effects on the uncommon outcome of failure
to receive a callback. In such circumstances, the study would
then have tended to find a greater effect of a criminal record on
the failure to receive callbacks on whites than blacks, just as
having low income would be found to increase mortgage
rejection rates more for whites than for blacks.
More generally, in most cases where an observer draws an
inference based on, or posits an explanation for, the
comparative size of relative differences in a favorable or
adverse outcome, the relative difference as to the opposite
outcome would support a different inference or require a
different explanation.23 But invariably the perception about
the comparative size of the relative difference will lack a
sound statistical basis. That holds as well with respect to
inferences based on the comparative size of absolute
differences.
Lending and Discipline Disparities
The failure to understand the contrasting patterns by which
relative differences in favorable outcomes are affected by the
prevalence of an outcome is implicated in two perverse federal
law enforcements policies that have been much in the news in
recent years. In “Race and Mortality” I discussed the fact that
out of concern that standard lending criteria were responsible
for large racial differences in mortgage rejection rates federal
regulators had encouraged lenders to relax those criteria. That
approach accorded with longstanding policy concerning the
racial impact of employment tests, where lowering cutoffs was
regarded as a means of reducing such impact because it
reduced relative difference in pass rates. Lenders who relaxed
lending criteria in response to regulator encouragements pre-
sumably reduced relative differences in mortgage approval
rates. But as shown at the outset, while lowering standards
tends to reduce relative differences in satisfying them, it tends
to increase relative differences in failing to satisfy them.
Unaware of the latter pattern, regulators continued to monitor
the fairness of lender practices on the basis of relative differ-
ences in rejection rates. Thus, by responding to federal en-
couragement to relax criteria lenders increased the chances
that they would be sued for discrimination.
More recently the fair lending focus has been on differ-
ences between rates at which minorities and whites received
Table 7 White and black rates of receiving callbacks for tester applicants with and without convictions indicated on their applications, with measures of
difference











White 34 % 17 % 2.00 1.26 17 0.54
Black 14 % 5 % 2.80 1.10 9 0.56
22 The Subgroup Effects subpage of the Scanlan’s Rule page shows how
the EES can be used to determine whether the exists a subgroup effect in a
clinical trial and provides a basis for employing an observed risk reduction
in a clinical trial to estimate the absolute risk reduction for baseline rates
different from those in the trial.
23 See theWhitehall Studies subpage of the Measuring Health Disparities
page, the Disparities – High Income subpage of the Lending Disparities
page and the Criminal Records Effects subpage of the Scanlan’s Rule
page. For discussion of a complex issue concerning interpretations about
the likelihood that racial differences in discipline rates result from teacher/
administrator bias based on the fact that relative differences between
black and white discipline rates are larger for subjectively-identified than
objectively-identified misconduct, see the Offense Type Issues subpage
of the Discipline Disparities page.
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subprime rather than prime mortgage loans, as in the suits
underlying the $335 million and $175 million settlements
against Countrywide Financial Corporation and Wells Fargo
Bank that received widespread media attention in 2011 and
2012. But the complaints in both cases fault the lenders for
policies that fail to minimize the proportion of loans that are
subprime rather than prime, thus encouraging lenders to re-
duce the frequency of subprime loans. Because regulators
continue to monitor the fairness of practices on the basis of
relative differences in adverse outcomes, here, too, responsive
lenders increase their risk of litigation.
For some years, the Departments of Education (DOE) and
Justice (DOJ) have been attributing large relative racial and
ethnic differences in suspension and expulsion rates to zero
tolerance policies in effect in recent decades and have been
encouraging schools to relax standards in order to reduce
those differences. The agencies’ January 2014 release of
school discipline guidance, with a joint focus on generally
reducing discipline rates and reducing racial differences in
discipline rates, is the most recent and most prominent reflec-
tion of the agencies’ views on the matter. Various jurisdictions
have been relaxing standards while believing, in accordance
with the government’s expressed views, that doing so will
tend to reduce racial differences. Yet, as with any outcome,
reducing the frequency of suspensions and expulsions will
tend to increase, rather than reduce, relative differences in
experiencing such outcomes. Indeed, a November 2012
DOE school equity report shows smaller relative racial differ-
ences in expulsions in districts with zero tolerance policies
than in districts without such policies, and reductions in sus-
pension rates in the states of California and Maryland and the
cities of Los Angeles and Denver have been accompanied by
increased relative racial/ethnic differences in suspensions.24
Meanwhile, the government continues to appraise the fairness
of discipline policies on the basis of relative differences in
those outcomes. As in the lending context, school districts
responding to government encouragements to relax standards
tend to increase the chances that the government will sue them
for discrimination.
In March 2014, DOE and DOJ jointly released a discipline
disparities report that included information on demographic
disparities in suspensions from preschool programs. The re-
port elicited great concern that preschool administrators would
find reason to suspend preschoolers in other than the rarest of
cases as well as concern over what were perceived to be huge
racial disparities in suspension rates among preschoolers. No
one grasped the connection between the two issues, specifi-
cally, that relative differences in suspension rates tended to be
especially larger among preschoolers precisely because sus-
pension are so rare in preschools.
Table 8 presents the figures from the report on multiple
suspensions (which were the focus of much of the media
coverage) both for preschool and K-12. Once again we ob-
serve the patterns that persons with an understanding of risk
distributions would tend to expect – i.e., larger relative differ-
ences in the adverse outcome, but smaller relative differences
in the corresponding favorable outcome, in the setting where
the adverse outcome is less common. And the EES tells us
that, whatever the forces causing multiple suspension rates of
blacks and whites to differ, the strength of the forces is
essentially the same in preschool as in K-12. Perceptions
about the size of the preschool disparities, however, are likely
to cause general reduction in suspension rates among pre-
schoolers. That will tend to increase the relative differences
prompting the reductions.
The March 2014 report also found very large relative
differences between the discipline rates of students with and
without disabilities, something that had been noted in many
previous studies. These differences have been a subject of
sufficient concern that in the Individuals with Disabilities
Education Improvement Act of 2004 Congress mandated that
recipients of federal assistance with “significant discrepan-
cies” in rates of long-term suspensions of disabled and non-
disabled students must consider approaches to discipline of
the type that commonly reduce suspension rates. Such dis-
crepancies are invariably measured in terms of relative differ-
ences in adverse outcomes, which will tend to be greater
where suspension rates are generally lower. Thus, the
statute is likely to cause jurisdictions already with low
suspension rates to further lower those rates, thus increasing
the relative differences in suspensions that prompted the
modifications.
The measurement issues discussed here are also implicated
in interpretations about racial differences that DOE monitors
regarding academic outcomes. But neither DOE nor others
24 See the DOE Equity Report, California Disparities, Maryland Dispar-
ities, Los Angeles SWPBS, and Denver Disparities subpages of the
Discipline Disparities page. See also the Suburban Disparities subpage,
which discusses efforts to determine why relative racial difference in
discipline rates are larger in Philadelphia’s suburbs than in the city itself
without consideration of the implications of the generally low discipline
rates in the suburbs.
Table 8 White and black rates of multiple suspensions in preschool and K-12, with measure of difference
Level White mult susp rate Black mult susp rate B/W ratio mult susp W/B ratio no mult susp Percentage point diff EES
Preschool 0.15 % 0.67 % 4.41 1.01 0.52 0.49
K-12 2.23 % 6.72 % 3.01 1.05 4.49 0.51
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examining demographic differences in proficiency or non-
proficiency and graduation or dropout rates recognize that
overall changes in outcome rates commonly lead to an in-
crease in the relative difference as to one outcome and a
decrease in the relative difference as to the other outcome.
Increasingly, proficiency disparities tend to be monitored in
terms of absolute differences. But such monitoring is conduct-
ed without recognizing, for example, that overall improve-
ments will tend to increase absolute differences for subjects
with generally low proficiency rates but reduce absolute dif-
ferences for subjects with generally high proficiency rates.25
Looking Forward
In maintaining that all research into demographic differences
in outcome rates without consideration of the way the measure
employed is affected by the prevalence of an outcome has
been fundamentally flawed or misleading, I proceed from the
perspective that there is not much here about which reasonable
people can differ. While few people are aware of the patterns
reflected in Tables 1 and 2 or like patterns that can be illus-
trated with myriad other types of data, that does not make the
existence of the patterns in any sense debatable. And once the
patterns are recognized, one can hardly question their essential
implications respecting the use of standard measures to quan-
tify differences in the circumstances of two groups reflected
by a pair of outcome rates. For example, to return to the
question posed with regard to the patterns in Table 2, once
one understands the patterns, there exists no plausible justifi-
cation for exploring such things as the way particular policies
may affect racial differences in susceptibility to poverty with-
out consideration of those patterns.
That onemay observe departure from these patterns does not
alter the situation. Departures from the patterns in fact are the
principal, if not only, things worth exploring. Nor does the
accuracy of my descriptions of the patterns by which measure
tend to change as the prevalence of an outcome change matter
very much. As long as a measure tends to be in any way
affected by the prevalence of outcome, one cannot reasonably
rely on the measure to quantify the strength of an association
without considering the implications of such effect. At any rate,
no one has yet advanced a plausible rationale for doing so.
The matter is equally clear in the case of the federal fair
lending and public school discipline contexts. Once recogniz-
ing that lowering a test cutoff tends to increase relative differ-
ences in failure rates, a thoughtful person cannot long fail to
recognize that lowering a credit score requirement or increas-
ing the number of classroom infractions necessary to merit a
suspension will have like effect on relative differences in the
pertinent adverse outcomes.
Since 2004, more often in Europe than the United States,
researchers have been responding to “Race or Mortality” or
some prior or subsequent articulation of its main points (in-
cluding the 2006 Chance editorial). These responses are sum-
marized in the Consensus subpage of the Scanlan’s Rule page
of jpscanlan.com. While the responses do not necessarily
recognize the way the described patterns are inherent features
of the underlying risk distributions, they do recognize that
measures will commonly show the correlations with overall
prevalence that I have described. Such recognition, however,
has failed to affect research practices, even among authors of
works reflecting such recognition, and some of those authors
have gone on to do further work while ignoring the implica-
tions of their own conclusions that measures employed in such
work can only be useful if appraised with regard to the
prevalence of the outcome studied.
In recent years, I have formally contacted institutions
whose activities involve the interpretation of data on group
differences advising them of the ways those activities are
undermined by failure to recognize that standard measures
of differences between outcome rates tend to be systematically
affected by the prevalence of an outcome. This correspon-
dence and responses to it are available through the Institution-
al Correspondence subpage of the Measuring Health Dispar-
ities page of jpscanlan.com. It includes letters to the Depart-
ments of Justice and Education explaining that, contrary to
premises of federal civil rights enforcement policies, reducing
adverse borrowing and discipline outcomes tend to increase,
rather than reduce, relative differences in experiencing those
outcomes. The responses to this correspondence are revealing
of the limited ability of governmental institutions to compre-
hend and act on information of modest complexity even when
such information indicates that the institutions’ understand-
ings of crucial concepts are the exact opposite of reality.
Correspondence relating to Harvard University and certain
related entities also warrant brief treatment here. It is possible,
though by no means certain, that my 2009 and 2010 letters to
the National Quality Forum and the Robert Wood Johnson
Foundation had a role in causing those organizations to secure
the services of Harvard Medical School and the Disparities
Solution Center ofMassachusetts General Hospital to produce
a healthcare disparities measurement guide. The guide,
Commissioned Paper: Health Care Disparities Measurement
(Weissman et al. 2011), when released for public comment in
the summer of 2011, was superior to many such guides in the
scope of its coverage of measurement issues. It even pointed
out, though somewhat obscurely, that it is possible for relative
differences in favorable and adverse outcomes to yield differ-
ent conclusions about directions of changes in disparities over
time. But it showed no recognition whatever of the ways the
measures it discussed tended to be affected by the prevalence25 See the Educational Disparities page and its subpages.
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of an outcome. That remained the case after the authors
reviewed my comments bringing to their attention my work
and the work of others, including NCHS, addressing such
issues.26
By failing to address issues concerning the way measures
tend to change simply because the prevalence of an outcome
changes, the guide, in the final form issued in November
2011, will tend to lead readers to believe no such issues exist.
It thus has far greater potential to undermine healthcare dis-
parities research than to inform it.
In a lengthy October 2012 letter to Harvard University,
written in conjunction with the applied statistics workshop
referenced in note 2, and addressing a number of issues about
health and health disparities research at Harvard Medical
School and Harvard School of Public Health, I urged the
University to take steps to have the Commissioned Paper
withdrawn. In addition to summarizing the failings of the
Commissioned Paper, the letter provides a fair summary of
health and health disparities research at Harvard with respect
to the measurement issues addressed in this article. It shows
that none of that research recognizes that the measures on
which it relies tend to be affected by the prevalence of an
outcome. In fact, almost no Harvard research recognizes that a
measure other than that employed in a study might or would
yield a different conclusion concerning the comparative size
of two disparities in outcome rates, and none of it would lead
anyone to imagine that one might reach a different conclusion
about directions of changes in disparities over time if one
relied on relative differences in favorable outcomes rather than
relative differences in adverse outcomes. Thus, as with re-
search at other institutions around the world, both with respect
to its main findings and its hypothesizing about the fact that
one difference between outcome rates is larger than another,
Harvard’s health and healthcare disparities research is almost
invariably unsound.
Harvard did not respond to the letter. But the research
integrity officers of Harvard Medical School and Massachu-
setts General Hospital did respond to a follow-up letter elab-
orating on the reasons why the Commissioned Paper should
be withdrawn. The response stated that issues I raised
concerning the guide involved “a difference of scientific opin-
ion” and not research misconduct, and that, absent the latter,
and two institutions do not independently assess the merits of
individual papers of their faculty members. The institutions
therefore declined to withdraw the guide.
The letter did not explain the perceived difference of opin-
ion. But to the extent that there exists an articulable opinion
contrary to my own concerning the Commissioned Paper, it
would not merely be an opinion that one may in fact usefully
explore such things as the reasons for increasing relative racial
differences in some adverse outcome rate without consider-
ation of the implications of the general declines in the out-
come. It would also be an opinion that it is unnecessary for a
measurement guide to alert readers that there exists a body of
work maintaining that each of the measures discussed in the
guide is fatally flawed unless employedwith an understanding
of the way it tends to change as the prevalence of an outcome
changes.
The guide continues to bear on its cover the names of
HarvardMedical School andMassachusetts General Hospital,
as well as the National Quality Forum and the Robert Wood
Johnson Foundation. Because of the stature of those entities,
as well the guide’s currency, it is likely to influence a great
deal of health and healthcare disparities research and, in doing
so, contribute to the longstanding pattern wherebymost of that
research is wasteful even when it is not misleading. The guide
also continues to serve as a foundation document for other
health and healthcare disparities guidance of the National
Quality Forum and presumably plays a significant role in the
training of administrators in the Disparities Leadership Pro-
gram of the Disparities Solution Center of Massachusetts
General Hospital.
But it is a guide that should never have been published.
And by continuing to support it the aforementioned institu-
tions run the risk that they will undermine their credibility, not
only with regard to the measurement of demographic differ-
ences, but with regard to the manymore complex matters as to
which to they are believed to have great expertise. Like issues
exist with respect to health and healthcare disparities research
at Harvard Medical School and Harvard School of Public
Health, as well as Massachusetts General Hospital, if contin-
ued to be conducted without regard to the measurement issues
that at least the research integrity officers of Harvard Medical
School and Massachusetts General Hospital ought now to
fully understand. Such officers should recognize as well the
varied ethical issues in the conduct of research of any nature
that cannot be fully defended, issues that are heightened when
research is supported by government funds.
Many other institutions whose activities involve equally
flawed analyses of demographic differences face similar risks.
But few are in as good a position as Harvard and Massachu-
setts General Hospital to know better.
The ideas I expressed in “Race and Mortality” and varied
other works about measuring demographic differences have
yet to materially affect the way observers analyze demograph-
ic differences. But the issues I have raised are not matters of
26 In response to my assertion that health and healthcare disparities
research was universally flawed for failure to recognize the ways standard
measures tend to be affected by the prevalence of an outcome, the authors
added eight words at the end of a sentence in the report such that it would
now read: “While calculations of disparities can be straightforward,
comparisons of disparities among entities or over time can be sensitive
to the calculations chosen, especially when the prevalence of an outcome
changes.”
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nuance. And whatever time it takes, I have little doubt that
there will eventually be universal recognition of the patterns
described here and of the implications of those patterns. The
first such recognition may involve the research community’s
appraisal of differences in health or healthcare outcomes or
other social issues or that community’s interpretation of data in
clinical contexts with respect to things like subgroup effects. Or
it may involve the federal government’s either recognizing on
its own, or being forced to recognize, that it encourages entities
to take actions that make it more likely that the government will
sue them. Once that recognition occurs in one of these areas, it
may or may not spread quickly to the others. But it will
eventually come in each of these areas as well as in others
where the implications of the patterns have escaped my notice.
It will be to the advantage of all that the recognition comes
sooner rather than later.
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